Practice Guideline
NCCN guideline updates: colon and rectal cancers, version 1.2004
- PMID: 19795595
Item in Clipboard
Practice Guideline
NCCN guideline updates: colon and rectal cancers, version 1.2004
J Natl Compr Canc Netw.
2004 Jul.
No abstract available
Similar articles
-
Update: NCCN colon and rectal cancer clinical practice guidelines.J Natl Compr Canc Netw. 2004 Sep;2 Suppl 3:S-14-8. J Natl Compr Canc Netw. 2004. PMID: 23570093 No abstract available.
-
Improved first-line chemotherapy: a better chance for surgery?Lancet Oncol. 2010 Jan;11(1):4-5. doi: 10.1016/S1470-2045(09)70345-6. Epub 2009 Nov 26. Lancet Oncol. 2010. PMID: 19942480 No abstract available.
-
New treatments for colon cancer.BMJ. 2004 Jul 17;329(7458):124-6. doi: 10.1136/bmj.329.7458.124. BMJ. 2004. PMID: 15258046 Free PMC article. No abstract available.
-
The clinical efficacy of FOLFIRI and bevacizumab in combination as first-line therapy of metastatic colorectal cancer.Clin Colorectal Cancer. 2007 Sep;6(9):621-4. doi: 10.1016/S1533-0028(11)70301-2. Clin Colorectal Cancer. 2007. PMID: 17945033 Review. No abstract available.
-
[Chemotherapy of metastasizing cancers of the colon and rectum].Ann Chir. 1993;47(6):480-3. Ann Chir. 1993. PMID: 7692804 Review. French. No abstract available.
Cited by
-
Effect of primary tumor location and tumor size on the response to radiotherapy for liver metastases from colorectal cancer.Oncol Lett. 2017 Jul;14(1):453-460. doi: 10.3892/ol.2017.6167. Epub 2017 May 12. Oncol Lett. 2017. PMID: 28693191 Free PMC article.
-
Survival and time interval from surgery to the start of chemotherapy for patients with stage II and III colon cancer.Acta Med Litu. 2018;25(3):161-165. doi: 10.6001/actamedica.v25i3.3863. Acta Med Litu. 2018. PMID: 30842705 Free PMC article.
-
The impact of delayed commencement of adjuvant chemotherapy (eight or more weeks) on survival in stage II and III colon cancer: a national population-based cohort study.Oncotarget. 2017 May 10;8(45):80061-80072. doi: 10.18632/oncotarget.17767. eCollection 2017 Oct 3. Oncotarget. 2017. PMID: 29108388 Free PMC article.
-
Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies.Ann Oncol. 2014 Mar;25(3):663-668. doi: 10.1093/annonc/mdt578. Epub 2014 Jan 23. Ann Oncol. 2014. PMID: 24458473 Free PMC article.
-
Generation and external validation of a tumor-derived 5-gene prognostic signature for recurrence of lymph node-negative, invasive colorectal carcinoma.Cancer. 2012 Nov 1;118(21):5234-44. doi: 10.1002/cncr.27628. Epub 2012 May 17. Cancer. 2012. PMID: 22605513 Free PMC article.